What are the contraindications for colestiramine (bile acid sequestrant) administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Contraindications for Cholestyramine Administration

Cholestyramine is absolutely contraindicated in patients with complete biliary obstruction where bile is not secreted into the intestine and in individuals with hypersensitivity to any of its components. 1

Primary Contraindications

  • Complete biliary obstruction 1
  • Hypersensitivity to cholestyramine or its components 1
  • Triglycerides >500 mg/dL 2, 3
  • History of hypertriglyceridemia-induced pancreatitis 2, 3
  • Bowel obstruction 2, 3
  • Extensive ileal resection (>100 cm) or severe ileal involvement 3

Precautions and Relative Contraindications

Gastrointestinal Concerns

  • Use with caution in patients with:
    • Gastroparesis 2
    • GI motility disorders 2
    • History of major GI tract surgery with risk for bowel obstruction 2

Medication Interactions

  • May decrease absorption of other medications 2
  • Critical medications should be administered at least 4 hours before cholestyramine 2
  • Specific medications requiring separation:
    • Cyclosporin
    • Oral contraceptives containing ethinyl estradiol and norethindrone
    • Olmesartan
    • Phenytoin
    • Sulfonylureas
    • Thyroid replacement therapy
    • Warfarin 2

Nutritional Considerations

  • May cause vitamin K or fat-soluble vitamin deficiencies 2
  • Oral vitamins should be given at least 4 hours before cholestyramine 2
  • Some products contain phenylalanine, which is harmful to patients with phenylketonuria 2

Monitoring Recommendations

  1. Triglyceride levels: Monitor closely as cholestyramine may increase triglycerides 2, 3
  2. Signs of pancreatitis: Discontinue if symptoms develop 2
  3. INR: Monitor frequently during initiation in patients on warfarin 2
  4. Vitamin levels: Consider monitoring fat-soluble vitamins in long-term use 2, 3

Clinical Considerations

When prescribing cholestyramine, start at a low dose (2-4 g/day) and gradually titrate based on response and tolerability 3. This approach helps minimize common gastrointestinal side effects such as constipation, dyspepsia, and nausea 2.

For patients who cannot tolerate cholestyramine due to palatability or side effects, consider colesevelam as an alternative, which has better tolerability and fewer drug interactions, though at higher cost 2, 3.

Remember that while cholestyramine is generally considered safe during pregnancy and lactation 2, individual risk-benefit assessment should be performed in these populations.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Lipid Management with Bile Acid Sequestrants

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.